Related Experiment Video
Updated: Jul 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Cost effectiveness of lipid lowering therapy]
G Wendland1, G Klever-Deichert, K Lauterbach
1Institut für Gesundheitsökonomie und klinische Epidemiologie, Köln. guido.wendland@medizin.uni-koeln.de
Statins are cost-effective for secondary prevention of coronary heart disease (CHD). Their cost-effectiveness in primary prevention depends on individual CHD risk, with benefits seen at a 1.5% annual risk.
Area of Science:
- Health Economics
- Pharmacoeconomics
- Cardiovascular Disease Prevention
Context:
- Increasing pressure for healthcare cost savings necessitates robust economic evaluations.
- Lipid-lowering therapies, particularly statins, are crucial in managing cardiovascular health.
- Methodological considerations significantly influence the interpretation of cost-effectiveness analyses.
Purpose:
- To evaluate the cost-effectiveness of statin therapy in the prevention of coronary heart disease (CHD).
- To compare the effectiveness of different lipid-lowering therapies, including non-pharmacological interventions and statins.
- To determine the threshold for CHD risk at which statin therapy becomes both effective and efficient.
Summary:
- Statins demonstrate cost-effectiveness in secondary prevention of CHD from a social insurance perspective.
- In primary prevention, the cost-effectiveness of statins is contingent on the patient's initial CHD risk.
- A yearly CHD risk of approximately 1.5% is identified as a threshold for cost-effective statin therapy.
Impact:
- Provides evidence for healthcare decision-makers regarding the economic value of statin therapy.
- Informs resource allocation in cardiovascular disease prevention strategies.
- Highlights the importance of risk stratification in optimizing the use of lipid-lowering medications.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

